Mobidiag UK

Mobidiag UK

Our goal: develop innovative molecular diagnostic solutions to advance the diagnosis of infectious diseases and antibiotic resistances. Mobidiag is a commercial stage, fast-growing Finnish-French biotechnology company. At Mobidiag, we develop and market innovative molecular diagnostic solutions for Gastrointestinal Infections, Antimicrobial Resistance Management, Healthcare Associated Infections (HAIs), Respiratory Infections and Sepsis. Based on well-established qPCR and microarray technologies, Mobidiag offers a broad range of tests and automated platforms. These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and antibiotic resistances.

Want to learn more?

Contact us

CPD Subsectors

Scientific Organisations
Scientific Research